Gene-ChainCoin Token Sale: Storing genomic data on a blockchain - Smith + Crown

Gene-ChainCoin Token Sale: Storing genomic data on a blockchain

Gene-Chain will be a platform for patients and researchers to securely store and exchange genomic data.

Project Description

Gene-ChainCoin was founded by David R. Koepsell to be a platform for patients and researchers to securely store and exchange genomic data.  David Koepsell is a J.D./Ph.D and the author of several books, including Who Owns You?: Science, Innovation and the Gene Patent Wars.

Gene-ChainCoin will be the unit of exchange for sending and receiving data over the network as well as the sole means of payment.

Project Details

Incorporation status: Encrypgen, LLC, Florida, 2017
Team openness: Fully transparent
Blockchain Developer: Unclear
Technical White Paper:       Doesn’t fully explain privacy and security issues
Available Project Code: No code available
Prototype: None available

Token Details

Role of token: Payment rights
Token supply: 100 million
Distributed in ICO:        10 million
Emission rate: 10% per year
Blockchain: Gene-ChainCoin
Consensus method: Unclear

Sale Details

Sale period: June 1st, 2017 to July 18th, 2017
First price: $0.25
Accepted currencies: BTC
Investment Round: First public offering
Token distribution date: September 1st, 2017
Min investment goal: None
Max investment cap: None
How are funds held: Unclear
Minimum Viable Product:        Unclear

Official Resources